ArticlePloS one2026
Transportation-related factors, cancer screening, and stage at diagnosis: A scoping review.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOver 4 million Americans annually miss healthcare appointments - including for cancer screening and treatment - due to transportation insecurity. We performed a scoping review to understand how transportation affects cancer screening and stage at diagnosis, and to make recommendations for measuring transportation-related factors in this context.
methodsWe searched PubMed, TRID, Embase, Scopus, and Web of Science for full-length, English-language, quantitative observational studies published from January 1, 2003 to June 12, 2025. We included observational studies on screening or stage measuring transportation barriers quantitatively at the patient level. Two authors reviewed content, extracted data, and assessed quality. We compared methods of measuring transportation-related factors and associations between these factors and screening/stage at diagnosis.
resultsWe screened 4567 abstracts, reviewed 446 full papers, and identified 53 screening and 43 stage at diagnosis studies after quality assessment. Transportation exposures were classified into travel distance/time, vehicle access, public transit, needing help to travel, patient perception of distance/time, and patient perception of transportation access. Travel distance/time accounted for 74% of analyses, and results were mixed between worse cancer outcomes for farther travelers (47%) and null or reversed results, but these findings were moderated by rurality and sociodemographic status. Owning a vehicle and being able to travel independently were associated with better clinical outcomes. Per quality assessment, papers were susceptible to referral and information bias; additionally, spatial auto-correlation and the hierarchical nature of data were frequently ignored leading to inflated effects.
conclusionsFuture research should go beyond "travel distance" to include alternative measures like vehicle ownership, car-less episodes, and needing help to travel to holistically evaluate transportation as a social driver of health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.